首页> 外文期刊>新薬と臨牀 >高血圧患者に対する塩酸イミダブリルの有用性,特に空咳発現について,マレイン酸エナラプリルを対照とした比較検討 多施設共同空咳発現頻度調査
【24h】

高血圧患者に対する塩酸イミダブリルの有用性,特に空咳発現について,マレイン酸エナラプリルを対照とした比較検討 多施設共同空咳発現頻度調査

机译:马来酸enalapril对比的多中心VAALCHAIN表达的比较检查,特别是对于高血压患者,特别是用于真空表达。

获取原文
获取原文并翻译 | 示例
       

摘要

The incidence of cough and antihypertensive effect of imidapril were compared to those of enalapril by a cross over method in mild to severe hypertensive patients as a multicenter trial.Doctors in 196 institutes participated in this study and 539 patients were enrolled. The data in 489 of 539 patients in whom the study was correctly conducted on the protocol were analyzed.In 246 of 489 patients, imidapril (5-10mg/day) was given as an initial drug for 12 weeks and then it was switched to enalapril. Enalapril was also administered for 12 weeks. On the other hand, in 243 of 489 patients, enalapril (5-10mg/day) was given as an initial drug for 12 weeks and then it was switched to imidapril.To evaluate the incidence and the degree of cough induced by ACE inhibitors, the questionnaires were performed before the administration of drugs and every 4 weeks, and blood examinations were performed before the administration of drug, at the end of initial treatment and at the end of the study.1.The frequency of cough was significantly higher in the enalapril group (85/220, 38.6%) than in the imidapril group (32/210, 15.2%).The difference of the frequency was about 2.5 times.2.20.9% of the patients in whom cough was not observed by imidapril developed cough affer switching to enalapril.On the other hand,0.9% of the patients in whom cough was not observed by enalapril developed cough on imidapril.3.52.8% (37/70) of the patients in whom cough was observed by enalapril, didn't have cough after switching to imidapril. On the other hand, all of the patients in whom cough was observed by imidapril had cough after switching to enalapril.4.No significant difference was observed in antihypertensive effect between imidapril (115/180,63.9%) and enalapril (121/223,54.3%).5.No significant difference was observed in overall safety assessed as "no clinical problems" between imidapril(168/213,78.9%)and enalapril (121/223, 54.3%).From these results, it was considered that antihypertensive effect of imidapril is similar to those of enalapril, but the incidence of cough induced by imidapril is about a half of enalapril.
机译:将止咳和抗高血压作用的发病率与伊纳普里尔的抗高血压作用相比,通过轻度至严重的高血压患者作为一种多中心试验。196年参加了这项研究的研究院,并注册了539名患者。分析了该研究的539例患者的489名数据。在489名患者的246名中,IMIDAPRIL(5-10mg /天)作为初始药物为12周,然后切换至烯丙醇。氯普里尔也被施用12周。另一方面,在489名患者的243名中,将烯丙烯兰(5-10mg /天)作为初始药物给出12周,然后切换到咪达普里尔。评估ACE抑制剂诱导的咳嗽的发病率和咳嗽程度,调查问卷在药物施用之前进行,每4周一次进行,并且在初始治疗结束时和研究结束时进行血液检查。咳嗽的频率显着高得多Enalapril组(85/220,38.6%)比IMIDAPRIL组(32/210,15.2%)。频率的差异约为2.5倍的患者患者未观察到的患者伊米达普罗尔发达另一方面,咳嗽的转向Enalapril.on,eNalapril未观察到咳嗽未观察到咳嗽的患者的0.9%的患者(37/70),并未发现咳嗽咳嗽的患者切换到Imidapril后有咳嗽。另一方面,在切换到烯丙醇后,Imidapril观察到咳嗽的所有患者都咳嗽。在伊米达普尔(115 / 180,63.9%)和丙普里尔(121/223)之间的抗高血压作用中观察到显着差异54.3%)。5.在综合安全性中观察到癌症(168 / 213,78.9%)和烯丙醇(121/223,54.3%)之间的“无临床问题”评估了显着差异。从这些结果中,它被认为是Imidapril的抗高血压作用类似于伊纳普利那些,但Imidapril诱导的咳嗽的发病率约为烯丙醇的一半。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号